 Adoptive immunotherapy human pancreatic cancer lymphokine-activated killer cells nude mouse model pancreatic cancer cell line orthotopic heterotopic positions young Swiss/NIH nude mice adoptive immunotherapy Mice human cancer cells subcutaneous tissue duodenal lobe pancreas mice groups group IA LAK human lymphokine-activated killer LAK cells normal donors tail vein injection units human recombinant hours days group IB dose group IC placebo consisting ml hours group ID LAK LAK cells Toxicity group IB mortality rate animals mortality group IA None group IA IB animals pancreatic cancer experiment animals days group IC group ID area growth curve subcutaneous tumors course treatment pancreatic tumor weight end treatment group Subcutaneous tumors reduced rate growth group IA animals treatments Pancreatic tumor growth group IA animals group IB slowing tumor growth intermediate group IA group IC group ID similar experiment irradiated rad mice Nine nude mice tumors LAK group IIA group IIB placebo group IIC antitumor effect present irradiated mice significant difference group IIA groups difference histologic characteristics tumors control mice mice inhibited tumor growth human LAK cells results adoptive immunotherapy human LAK cells human recombinant effective human pancreatic cancer nude mice effect independent antitumor activity administrations